Answers are grounded in this paper and cite their sources.
The appearance of metastases many years after primary treatment is not rare. The factors which determine prolonged latent periods are unknown. The belief that metastases which are latent for many years pursue a slow course after clinically evident, was not substantiated in several instances. This study undertook to identify possible characteristics of such patients and determine their fate. Fifty-seven women with breast cancer whose recurrences developed 5 years or more after treatment were studied. Whereas the mean interval from treatment to recurrence was 10.4 years, the mean survival time after recurrence averaged 1.9 years. A comparison of this group with another group of 66 patients who developed recurrences between one and 2 years after treatment revealed only a slight and statistically insignificant (P < .09) difference in survival time after recurrence between these groups. In the majority of patients in this study metastatic breast cancer remaining latent for prolonged periods tends to pursue a comparatively rapid course once it becomes clinically manifest; this is only slightly different from the patient with early recurrence. However, a small percentage of patients in both groups will survive for long periods of time after metastases appear.
No takes yet. Share an insight, caveat, or question.
Papaioannou et al. (1967) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: